Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Medication Guide

Gabapentin

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference partial Not FDA-approved for animals Multiple FDA labelers Official label facts Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts
Reference refreshed
Aug 6, 2026, 7:47 p.m.

Roxee has a partial reference profile for this medication. Some primary facts still need verification.

FDA applications
FDA application data refreshed
Aug 6, 2026, 7:47 p.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
Aug 6, 2026, 7:49 p.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Illustration placeholder
Gabapentin

Gabapentin

Drug type: Generic ingredient • Branded profile • Not FDA-approved for animals

Both 86% reference complete

Species: Both

Approval status: Not FDA-approved as an animal drug. No FDA-approved animal-drug application is linked for this record. It may represent extra-label, human-drug, bulk-compounding, export-only, or otherwise unapproved animal-use source data; use only under veterinarian direction.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Gabapentin

Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases. Species commonly shown: Both.

Generic name
Gabapentin
Brand names
GABAPENTIN, SolutitionKits
Manufacturer
Multiple FDA labelers
Species
Both
Completeness
86%
Validation
Incomplete
Brand names
GABAPENTIN SolutitionKits

Indications / Uses

Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.

Administration / How To Give

Oral

Storage

Store at room temperature.

Warnings / Contraindications

Use caution with kidney disease; dose adjustments may be needed.

  • Use caution with kidney disease; dose adjustments may be needed.

Side Effects

Sedation, ataxia, mild GI upset.

FAQ

Both

Store at room temperature.

Related Medications

Bedinvetmab Same category: Pain & Arthritis Carprofen Same category: Pain & Arthritis Deracoxib Same category: Pain & Arthritis Grapiprant Same category: Pain & Arthritis Meloxicam Same category: Pain & Arthritis Robenacoxib Same category: Pain & Arthritis

Related Conditions

Pain (acute, chronic)

Source Transparency

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • Use caution with kidney disease
  • dose adjustments may be needed
  • Thrombocytopenia (4 reports)
  • Elevated symmetrical dimethylarginine (4 reports)
  • Conjunctivitis (3 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?

Next actions

Talk to a Vet / Find a Vet Near You Save to pet meds Share page Review report evidence
Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Gabapentin; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA reaction aggregate term
Safety signal coverage Reported signals

32 tracked reaction signals; 60 reported cases; 7 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA reaction aggregate term
Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA reaction aggregate term
Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Thrombocytopenia (4 reports), Elevated symmetrical dimethylarginine (4 reports), Conjunctivitis (3 reports), Urolithiasis (2 reports), Unclassifiable adverse event (2 reports)

Body systems represented Signal grouping

Effectiveness (1), Other (31)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Dog (48 reports), Cat (12 reports)

Breed metadata in reports Metadata only

Domestic Shorthair (2), Retriever - Labrador (2), Schnauzer - Miniature (1), Crossbred Canine/dog (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Gabapentin fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

Use caution with kidney disease, dose adjustments may be needed, Thrombocytopenia, Elevated symmetrical dimethylarginine, Conjunctivitis

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Gabapentin brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
  1. openFDA reaction aggregate term · adverse_reaction · adverse reactions
  2. Medication contraindications · safety_warning · warnings contraindications
  3. Structured Product Label · document · documents
  4. Structured Product Label · document · documents
  5. Structured Product Label · document · documents
  6. Structured Product Label · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: April 15, 2026, 10:04 AM UTC

Sources:
Safety & side effects

Side effects to monitor:

  • Use caution with kidney disease
  • dose adjustments may be needed
  • Thrombocytopenia
  • Elevated symmetrical dimethylarginine
  • Conjunctivitis

Most reported reactions:

  • Thrombocytopenia (4 reports)
  • Elevated symmetrical dimethylarginine (4 reports)
  • Conjunctivitis (3 reports)
Explore reported case details

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species
Not linked yet
Indication / use
Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.
Form / route / dose
Confirm product label and patient-specific plan.
Warnings
  • High: Use caution with kidney disease; dose adjustments may be needed.
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Multiple FDA labelers
Identifiers:
NDC Package: 46144-600-01 NDC Package: 62157-711-01 NDC Package: 73377-176-01 NDC Package: 86032-041-01 NDC Product: 46144 NDC Product: 62157 NDC Product: 73377 NDC Product: 86032

Warnings / Contraindications

Use caution with kidney disease; dose adjustments may be needed.

  • High: Use caution with kidney disease; dose adjustments may be needed.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
164
Matching reports
27
Active filters
1
Selected filters
Body system: Skin & allergy Clear
Reset
Drill into common report signals
Lethargy (see also Central nervous system depression in Neurological) (35) Abnormal radiograph finding (22) Death by euthanasia (18) Intentional misuse (18) Other (152) Neurologic (62) Digestive (50) Skin & allergy (27)
Showing up to 50 matching reports.

USA-USFDACVM-2026-US-014454

Received 2026-03-26 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (3.992 Kilogram)
Age
8+ years (11 Year)
Sex
Female Unknown
Region
USA
Reactions
Facial pruritusMedication error NOS
Body systems
Skin & allergyOther
Outcomes
Recovered/Normal

USA-USFDACVM-2026-US-014065

Received 2026-03-24 · MSK · MSK

Serious
Species
Dog
Breed
Retriever - Golden
Size / weight
50-99 lb (34.019 Kilogram)
Age
4-7 years (4 Year)
Sex
Female Unknown
Region
USA
Reactions
LamenessDifficulty to riseJoint swellingAbnormal radiograph findingBone and joint disorder NOSDiscomfort NOS
Body systems
OtherSkin & allergy
Outcomes
Ongoing

USA-USFDACVM-2026-US-013826

Received 2026-03-24 · MSK · MSK

Serious
Species
Dog
Breed
Chihuahua
Size / weight
Under 10 lb (4.173 Kilogram)
Age
8+ years (12 Year)
Sex
Female Unknown
Region
USA
Reactions
Luxation/subluxationLack of efficacy - NOSJoint swellingBone and joint disorder NOSPain NOSLamenessHyperextension
Body systems
OtherEffectivenessSkin & allergy
Outcomes
Ongoing

USA-USFDACVM-2026-US-012895

Received 2026-03-19 · MSK · MSK

Serious
Species
Dog
Breed
Shepherd Dog - German
Size / weight
50-99 lb (30.844 Kilogram)
Age
4-7 years (4 Year)
Sex
Female Unknown
Region
USA
Reactions
Injection site painInjection site swellingEmesis (multiple)Decreased appetitePica NOSLocalised pain NOS (see other SOCs for specific pain)Eosinophilia
Body systems
OtherSkin & allergyDigestive
Outcomes
Ongoing

USA-USFDACVM-2026-US-012892

Received 2026-03-17 · MSK · MSK

Non-serious
Species
Dog
Breed
Bloodhound
Size / weight
100+ lb (68.492 Kilogram)
Age
8+ years (8 Year)
Sex
Male Neutered
Region
USA
Reactions
LimpingPain NOSTorn ligamentJoint swellingBone and joint disorder NOSPlantigrade postureAbnormal radiograph findingMedication error NOS
Body systems
OtherSkin & allergy
Outcomes
Ongoing

USA-USFDACVM-2026-US-013537

Received 2026-03-16 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Longhair
Size / weight
Under 10 lb (4.47 Kilogram)
Age
4-7 years (7 Year)
Sex
Female Neutered
Region
USA
Reactions
Localised hair lossReddening of the skinItchy skinWoundDermal thickeningAbnormal cytologyIntentional misuseLocal swelling (not application site)Reverse sneezingLeukocytosis NOSThrombocytopeniaNeutrophiliaMonocytosisSkin lesion NOS
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2026-US-013313

Received 2026-03-16 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (6.427 Kilogram)
Age
8+ years (13 Year)
Sex
Female Neutered
Region
USA
Reactions
PruritusSkin lesion NOSSkin scab
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2026-US-013584

Received 2026-03-13 · MSK · MSK

Non-serious
Species
Dog
Breed
Crossbred Canine/dog
Size / weight
25-49 lb (15.876 Kilogram)
Age
8+ years (1 Year)
Sex
Female Neutered
Region
USA
Reactions
ItchingLicking
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2026-US-011996

Received 2026-03-13 · MSK · MSK

Serious
Species
Dog
Breed
Terrier - Bull - American Pit
Size / weight
50-99 lb (29.937 Kilogram)
Age
4-7 years (5 Year)
Sex
Male Neutered
Region
USA
Reactions
Injection site painAnorexiaFeverInjection site swellingInjection site abscessLethargy (see also Central nervous system depression in Neurological)
Body systems
OtherDigestiveSkin & allergyNeurologic
Outcomes
Ongoing

USA-USFDACVM-2026-US-011585

Received 2026-03-13 · MSK · MSK

Serious
Species
Dog
Breed
Collie - Smooth-haired
Size / weight
50-99 lb (30.9 Kilogram)
Age
8+ years (11 Year)
Sex
Female Unknown
Region
USA
Reactions
Generalised itchingIncreased drinkingPolyuria
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2026-US-013136

Received 2026-03-11 · MSK · MSK

Serious
Species
Dog
Breed
Shepherd Dog - German
Size / weight
50-99 lb (38.918 Kilogram)
Age
4-7 years (5 Year)
Sex
Female Intact
Region
USA
Reactions
Swelling NOSLamenessBone and joint disorder NOSAbnormal radiograph finding
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2026-US-010347

Received 2026-03-03 · MSK · MSK

Serious
Species
Dog
Breed
['Shepherd Dog - German', 'Retriever - Labrador']
Size / weight
50-99 lb (29.166 Kilogram)
Age
8+ years (1 Year)
Sex
Female Unknown
Region
USA
Reactions
LimpingMusculoskeletal disorder NOSLocal swelling (not application site)Hot spot (pyotraumatic dermatitis)LickingNot himself/herselfElevated serum alkaline phosphatase (ALP)Elevated blood urea nitrogen (BUN)Elevated creatinineNeutrophiliaDeathMedication error NOS
Body systems
OtherSkin & allergy
Outcomes
Died

USA-USFDACVM-2026-US-010698

Received 2026-02-24 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (6.427 Kilogram)
Age
8+ years (13 Year)
Sex
Female Neutered
Region
USA
Reactions
PruritusSkin lesion NOSSkin scabLabeled drug-species interactionIntentional misuse
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2026-US-010643

Received 2026-02-12 · MSK · MSK

Non-serious
Species
Dog
Breed
Retriever - Golden
Size / weight
50-99 lb (30.844 Kilogram)
Age
4-7 years (6 Year)
Sex
Female Unknown
Region
USA
Reactions
Localised pain NOS (see other SOCs for specific pain)Limb non-weight bearingSwollen limbWhiningUncomfortablePain NOSReluctant to moveInappropriate urinationAbnormal urine odourInjection site bleedingAnorexiaInjection site itchingInjection site irritationInjection site self traumaLimpingInjection site discharge NOSSkin irritationReddening of the skinAlopecia localInjection site scratchingInjection site swellingInjection site hair loss
Body systems
OtherDigestiveSkin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2026-US-008917

Received 2026-01-29 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (6.53 Kilogram)
Age
1-3 years (1.33 Year)
Sex
Male Neutered
Region
USA
Reactions
PtyalismTremorSeizure NOSAggressionLeukocytosis NOSNeutrophiliaEosinopeniaHypernatraemiaElevated cholesterol (total)Eyes rolling backHyperactivityElevated haematocritDisorientationUrinary tract obstruction/blockageAnaemia NOSOther abnormal test result NOSMydriasisActing tenseMental confusionTwitchingBradycardiaDecreased heart rateBehavioural disorder NOSHaematuriaProteinuria
Body systems
OtherNeurologicBehaviorSkin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2026-US-007621

Received 2026-01-23 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (5.9 Kilogram)
Age
4-7 years (5 Year)
Sex
Male Neutered
Region
USA
Reactions
Injection site skin change NOSInjection site alopeciaInjection site weeping (see also Skin)DehiscenceInjection site mucopurulent dischargeInjection site necrosis
Body systems
OtherSkin & allergy
Outcomes
Recovered/Normal

USA-USFDACVM-2026-US-003253

Received 2026-01-16 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (6.53 Kilogram)
Age
1-3 years (1.33 Year)
Sex
Male Neutered
Region
USA
Reactions
PtyalismTremorSeizure NOSAggressionLeukocytosis NOSNeutrophiliaEosinopeniaHypernatraemiaElevated cholesterol (total)Eyes rolling backHyperactivityElevated haematocritDisorientationUrinary tract obstruction/blockageAnaemia NOSOther abnormal test result NOSMydriasisActing tenseMental confusionTwitchingBradycardiaDecreased heart rateBehavioural disorder NOSHaematuriaProteinuria
Body systems
OtherNeurologicBehaviorSkin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-075379

Received 2025-12-23 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (8.618 Kilogram)
Age
4-7 years (7 Year)
Sex
Male Neutered
Region
USA
Reactions
Injection site hair lossReddening of the skinWeight lossSkin lesion NOSWoundAbnormal cytologyDiscomfort NOSSkin necrosisItchingFacial swelling (see also Skin)Facial rash (For urticaria see Immune SOC)
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-074820

Received 2025-12-22 · MSK · MSK

Non-serious
Species
Dog
Breed
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog)
Age
4-7 years (4.8 Year)
Sex
Male Neutered
Region
USA
Reactions
LimpingSwelling NOSLimb non-weight bearingConstipationLack of efficacy (endoparasite) - heartwormPain NOSPica NOSLocalised pain NOS (see other SOCs for specific pain)
Body systems
OtherSkin & allergyEffectiveness
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-074107

Received 2025-12-16 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (4.296 Kilogram)
Age
8+ years (11 Year)
Sex
Female Unknown
Region
USA
Reactions
PruritusAlopecia NOSSkin lesion NOSDermatitis
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-072787

Received 2025-12-15 · MSK · MSK

Serious
Species
Dog
Breed
Poodle - Standard
Size / weight
25-49 lb (20.412 Kilogram)
Age
1-3 years (2 Year)
Sex
Female Intact
Region
USA
Reactions
Death by euthanasiaConjunctivitisUlceration NOSEar canal erythemaWeltBumps on skinSkin inflammation NOSAnorexiaPain NOSDifficulty to risePyodermaAbnormal histology NOSSeizure NOSNeutropeniaMonocytosisElevated creatinineThrombocytopeniaHyperkeratosisPruritus
Body systems
OtherDigestiveNeurologicSkin & allergy
Outcomes
Euthanized

USA-USFDACVM-2025-US-074043

Received 2025-12-11 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (3.175 Kilogram)
Age
8+ years (9 Year)
Sex
Female Neutered
Region
USA
Reactions
Reddening of the skinItchingLocalised hair lossSkin irritation
Body systems
OtherSkin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-074653

Received 2025-12-09 · MSK · MSK

Serious
Species
Dog
Breed
['Pit Bull', 'Dog (unknown)']
Size / weight
50-99 lb (37.376 Kilogram)
Age
8+ years (11.5 Year)
Sex
Female Neutered
Region
USA
Reactions
Joint swellingBone and joint disorder NOSSarcoma NOS
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-072504

Received 2025-12-04 · MSK · MSK

Serious
Species
Dog
Breed
Terrier - Bull - American Pit
Size / weight
50-99 lb (29.03 Kilogram)
Age
1-3 years (2 Year)
Sex
Male Neutered
Region
USA
Reactions
Otitis externaTrigeminus paralysisVomitingCoughMuscle atrophy (see also Muscle wasting)Elevated serum alkaline phosphatase (ALP)Elevated alanine aminotransferase (ALT)HypersalivationUnusual stool colourErythema (for urticaria see Immune SOC)Elevated gamma-glutamyl transferase (GGT)Elevated total bilirubinAbnormal ultrasound findingHepatic fibrosisHepatitisLethargy (see also Central nervous system depression in Neurological)AngioedemaGeneralised rashDyspnoeaIncreased lung soundsLeucocytosis NOSIcterusAbnormal radiograph findingJaw disorder
Body systems
OtherDigestiveSkin & allergyNeurologic
Outcomes
Ongoing

USA-USFDACVM-2025-US-072174

Received 2025-12-01 · MSK · MSK

Non-serious
Species
Dog
Breed
Terrier - Yorkshire
Size / weight
10-24 lb (6.12 Kilogram)
Age
8+ years (13 Year)
Sex
Female Neutered
Region
USA
Reactions
Partial lack of efficacyAlopeciaErythema (for urticaria see Immune SOC)PapuleExcoriationSkin scabBacterial skin infection NOSAbnormal cytology
Body systems
EffectivenessSkin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-069108

Received 2025-11-19 · MSK · MSK

Serious
Species
Cat
Breed
Cat (other)
Size / weight
10-24 lb (5.352 Kilogram)
Age
8+ years (9 Year)
Sex
Male Neutered
Region
USA
Reactions
Skin lesion NOSFacial pruritusAlopecia
Body systems
OtherSkin & allergy
Outcomes
Ongoing

USA-USFDACVM-2025-US-070057

Received 2025-11-18 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (5.9 Kilogram)
Age
4-7 years (5 Year)
Sex
Male Neutered
Region
USA
Reactions
Injection site skin change NOSInjection site alopeciaInjection site weeping (see also Skin)DehiscenceInjection site mucopurulent dischargeInjection site necrosis
Body systems
OtherSkin & allergy
Outcomes
Ongoing

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
60
Serious reports
7
Species represented
2
Grouped by Body System
Effectiveness (1) · Lack of efficacy (endoparasite) - tapeworm Other (31) · Thrombocytopenia, Elevated symmetrical dimethylarginine, Conjunctivitis
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Other 4 Dog 0
Other 4 Dog 0
Other 3 Dog 0
Other 2 Dog 0
Other 2 Dog 0
Other 2 Dog 0
Other 2 Dog 0
Other 2 Dog 0

Species coverage: Dog (48) Cat (12)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Other Dog Unknown - 4
Other Dog Unknown - 4
Other Dog Unknown - 3
Other Dog Unknown - 2
Other Dog Unknown - 2
Other Dog Unknown - 2
Other Dog Unknown - 2
Other Dog Unknown - 2
Other Dog Unknown - 2
Other Dog Unknown - 2
Other Dog Unknown - 2
Other Dog Unknown - 2
Effectiveness Dog Unknown - 2
Other Dog Unknown - 2
Other Dog Unknown - 2
Other Cat Unknown - 2
Other Cat Unknown - 2
Other Dog Unknown - 2
Other Dog Unknown - 2
Other Cat Unknown - 2
Other Cat Unknown - 2
Other Cat Unknown - 2
Other Dog Unknown - 2
Other Cat Serious - 1
Other Dog Non-serious - 1
Other Cat Serious - 1
Other Dog Unknown - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Source metadata:

Storage & Handling

Store at room temperature.

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

Gabapentin SPL SPL · Structured Product Label Gabapentin SPL SPL · Structured Product Label SolutitionKits SPL SPL · Structured Product Label

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

4

FOI

0
No FOI links yet.

Gabapentin SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Gabapentin. Use the source link for the full official labeling record.

Gabapentin SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Gabapentin. Use the source link for the full official labeling record.

SolutitionKits SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for SolutitionKits. Use the source link for the full official labeling record.

GABAPENTIN SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for GABAPENTIN. Use the source link for the full official labeling record.
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: GABAPENTIN Gabapentin SolutitionKits
Manufacturer mapping: Multiple FDA labelers
Case-reported brands (openFDA): MSK
Catalog species: Both
NDC: Packages 46144-600-01 62157-711-01 73377-176-01 86032-041-01 • Products 46144 62157 73377 86032
Safety (openFDA)
Top reactions: Dog 382 • Cat 273 • View
Case summaries: 164 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Explore
Related conditions: Pain (acute, chronic)
Linked using: Usage_Inferred (0.78)
Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Use caution with kidney disease; dose adjustments may be needed. (Contraindication, High)
Top reaction signals
Thrombocytopenia (4) Elevated symmetrical dimethylarginine (4) Conjunctivitis (3) Urolithiasis (2) Unclassifiable adverse event (2) Trembling (2) Skin lesion NOS (2) Respiratory tract infection NOS (2)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
NDC Package: 46144-600-01 NDC Package: 62157-711-01 NDC Package: 73377-176-01 NDC Package: 86032-041-01 NDC Product: 46144 NDC Product: 62157 NDC Product: 73377 NDC Product: 86032
Package NDC Product NDC Form / Route Status
46144-600-01 46144 -
62157-711-01 62157 -
73377-176-01 73377 -
86032-041-01 86032 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • Gabapentin SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Gabapentin SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • SolutitionKits SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • GABAPENTIN SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 4 Clinical 120 Manufacturer 0 Marketing 0

Marketing/Manufacturer content exists: 1 linked manufacturer ad video are attached to this medication.

Current Field Facts
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-22)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-22)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-22)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-20)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-19)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-16)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-16)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-13)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-12)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-11)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-11)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-11)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-10)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-07)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-06)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-06)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-03)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-03)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-02)
  • contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-01)
Recent Revisions
  • side_effects updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-16 15:43 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-16 15:43 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published

Data source: FDA Animal Drugs @ FDA (public search export).

Usage

Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.

Contraindications

Use caution with kidney disease; dose adjustments may be needed.

Side Effects

Sedation, ataxia, mild GI upset.

Source: FDA openFDA • Reference

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Effectiveness
Lack of efficacy (endoparasite) - tapeworm (2) • Dog

Showing top 5 for Effectiveness.

Other
Thrombocytopenia (4) • Dog Elevated symmetrical dimethylarginine (4) • Dog Conjunctivitis (3) • Dog Urolithiasis (2) • Dog Unclassifiable adverse event (2) • Dog
Show more (26)
Trembling (2) • Dog Skin lesion NOS (2) • Dog Respiratory tract infection NOS (2) • Dog Regurgitation (2) • Dog Reduced globulins (2) • Dog Pyoderma (2) • Dog Proprioception deficit (2) • Dog Knuckling (2) • Dog Hypophosphataemia (2) • Dog Hypokalaemia (2) • Cat Hepatomegaly (2) • Cat Fracture (2) • Dog Erythema (2) • Dog Elevated alanine aminotransferase (2) • Cat Decreased activity (2) • Cat Death (2) • Cat Confusion (2) • Dog Abnormal radiograph finding (1) • Cat Abnormal movement NOS (1) • Dog Abnormal menace reflex test (1) • Cat Abnormal histology NOS (1) • Dog Abnormal cytology (1) • Dog Abdominal pain (1) • Dog Abdominal effusion (1) • Dog Abdominal discomfort (1) • Dog Abdominal cavity disorder NOS (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Cat, Domestic Shorthair, Female, 11 year, 3.992 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Facial pruritus, Medication error NOS • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2026-US-014454
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 11.00 Year
  • Weight: 3.992 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Facial pruritus Medication error NOS
Outcomes: Recovered/Normal

Dog, Retriever - Labrador, Male, 11 year, 47.174 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Partial lack of efficacy • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-014361
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 11.00 Year
  • Weight: 47.174 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Partial lack of efficacy
Outcomes: Ongoing

Dog, Schnauzer - Miniature, Male, 5 year, 10.16 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Lameness, Wobbliness, Tiredness (lethargy), Unable to walk, Weakness… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-014449
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 5.00 Year
  • Weight: 10.160 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Lameness Wobbliness Tiredness (lethargy) Unable to walk Weakness Fever Immune-mediated polyarthritis Gastritis Abdominal cavity disorder NOS Abnormal ultrasound finding Hyperproteinaemia Lymphopenia Eosinopenia Medication error NOS
Outcomes: Ongoing

Dog, Crossbred Canine/dog, Male, 10 year, 32.205 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Musculoskeletal disorder NOS, Aggression, Unable to walk, Urinary incontinence, Melaena… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2026-US-014374
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 10.00 Year
  • Weight: 32.205 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Musculoskeletal disorder NOS Aggression Unable to walk Urinary incontinence Melaena Vomiting Tiredness (lethargy) Death by euthanasia Neurological signs NOS
Outcomes: Euthanized

Dog, Retriever - Labrador, Unknown • Drug: MSK, Unknown • Reactions: Death • Outcome: Died

  • Report ID: USA-USFDACVM-2026-US-014204
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Unknown
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Death
Outcomes: Died

Cat, Domestic Shorthair, Female, 20 year, 2.631 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Agitation, Vocalisation, Unsteady walking (ataxia), Weakness • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2026-US-014011
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 20.00 Year
  • Weight: 2.631 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Agitation Vocalisation Unsteady walking (ataxia) Weakness
Outcomes: Recovered/Normal

Dog, Retriever - Golden, Female, 4 year, 34.019 kilogram • Drug: MSK, Unassigned, Unknown, Dose: 300 Milligram per animal, Frequency: 12 per hour • Reactions: Lameness, Difficulty to rise, Joint swelling, Abnormal radiograph finding, Bone and joint disorder NOS… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-014065
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 4.00 Year
  • Weight: 34.019 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
  • Dose: 300 Milligram per animal
  • Frequency: 12 per hour
Reactions Reported:
Lameness Difficulty to rise Joint swelling Abnormal radiograph finding Bone and joint disorder NOS Discomfort NOS
Outcomes: Ongoing

Dog, Shepherd Dog - German, Female, 9 year, 35.698 kilogram • Drug: MSK, Unassigned, Oral, Dose: 200 Milligram per animal, Frequency: 12 per hour • Reactions: Joint pain, Lameness, Depression, Difficulty standing, Decreased appetite… • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2026-US-014048
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 9.00 Year
  • Weight: 35.698 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
  • Dose: 200 Milligram per animal
  • Frequency: 12 per hour
Reactions Reported:
Joint pain Lameness Depression Difficulty standing Decreased appetite Abnormal radiograph finding Bone and joint disorder NOS Joint effusion Spondylosis
Outcomes: Outcome Unknown

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

Overdose can cause severe sedation, loss of coordination, muscle tremors, and respiratory depression. Emergency care: IV fluids, monitoring.

Storage & Handling

Store at room temperature.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.